Cost-utility analysis of human urinary kallindinogenase versus 3-n-butylphthalide for patients with mild or moderate acute ischemic stroke

GUAN Xin; ZHANG Yao; LI Hong-chao

doi:10.3969/j.issn.1003-3734.2020.06.019

Home>Articles>Cost-utility analysis of human urinary kallindinogenase versus 3-n-butylphthalide for patients with mild or moderate acute ischemic stroke

DOI: 10.3969/j.issn.1003-3734.2020.06.019

Cost-utility analysis of human urinary kallindinogenase versus 3-n-butylphthalide for patients with mild or moderate acute ischemic stroke

GUAN Xin

ZHANG Yao

LI Hong-chao

Machine-generated Keywords：

Publication Date：2020-03-31

Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)

Pages：6( 715-720 )

Chinese Journal of New Drugs

PKUISTIC

ISSN：1003-3734

Year, Vol.(Issue)：2020,29(6)